share_log

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Officer Vittiglio Joseph

bluebird bio | 4:持股變動聲明-高管 Vittiglio Joseph

SEC announcement ·  02/06 16:13
Moomoo AI 已提取核心訊息
Joseph Vittiglio, the Chief Business & Legal Officer of bluebird bio, Inc., completed a sale of 5,217 shares of common stock on February 5, 2024. The transaction was carried out on the open market with the shares sold at a price of $0.9025 each, resulting in a total sale value of $4,708.34. Following the sale, Vittiglio's direct holdings in the company amount to 44,783 shares of common stock.
Joseph Vittiglio, the Chief Business & Legal Officer of bluebird bio, Inc., completed a sale of 5,217 shares of common stock on February 5, 2024. The transaction was carried out on the open market with the shares sold at a price of $0.9025 each, resulting in a total sale value of $4,708.34. Following the sale, Vittiglio's direct holdings in the company amount to 44,783 shares of common stock.
藍鳥生物公司首席商務與法律官約瑟夫·維蒂格里奧於2024年2月5日完成了5,217股普通股的出售。該交易在公開市場上進行,股票以每股0.9025美元的價格出售,總銷售價值爲4,708.34美元。出售後,維蒂格里奧在該公司的直接持有量爲44,783股普通股。
藍鳥生物公司首席商務與法律官約瑟夫·維蒂格里奧於2024年2月5日完成了5,217股普通股的出售。該交易在公開市場上進行,股票以每股0.9025美元的價格出售,總銷售價值爲4,708.34美元。出售後,維蒂格里奧在該公司的直接持有量爲44,783股普通股。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息